Search results
Hace 3 días · ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
Hace 1 día · The ICON Digital Platform is an end-to-end solution to enable patient services throughout the clinical trial. Its ease of use supports patient centricity and reduces the barriers to trial participation thus enhancing equity, diversity and inclusion.
Hace 5 días · ICON is the world’s leading clinical research organisation, powered by healthcare intelligence. ICON applies innovation to drive emerging therapies forward and improve patient’s lives.
Hace 1 día · Oncology clinical development is often at the leading edge of innovative approaches to study designs through the use of novel approaches to enhanced patient care and clinically relevant endpoints. 1,2 Oncology has made substantial progress in the last 10 years. However, recently reported success rates across oncology phases 1 to 3 are still below 50%, with the transition from phase 2 to 3 ...
20 de jun. de 2024 · It can be integrated with any clinical trial system and a wide range of technologies including medical imaging, external EDC, CTMS, ePRO and laboratory systems, as well as ICON’s FIRECREST and ICONIK platforms, thereby providing complete visibility of your clinical data.
2 de jun. de 2024 · Leveraging AI in this way has demonstrated significant benefits for ICON’s clinical studies, improving demographic and geographically aligned site selection, recruitment rates, and start-up timelines. By taking a multifaceted approach that includes data analysis, community engagement, and broader inclusive trial practices, sponsors can ...
Hace 3 días · See the latest Icon PLC stock price (ICLR:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
